Latest news with #stockoptions
Yahoo
a day ago
- Business
- Yahoo
Sierra Madre Announces Grant of Stock Options
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2025) - Sierra Madre Gold and Silver Ltd. (TSXV: SM) (OTCQX: SMDRF) ("Sierra Madre" or the "Company") announces that, pursuant to its Stock Option Plan, it has granted stock options to employees of La Guitarra Compania Minera, S.A. de C.V., certain directors, management and consultants of the Company, to purchase an aggregate of 2,750,000 common shares of the Company at the price of $0.73 per share for a period of five years from the grant date. The Options shall be granted under and subject to the terms and conditions of the Company's stock option plan (the "Plan") and subject to the rules and policies of the Exchange. 40,000 of the options were granted to the Company's investor relations consultant, Adelaide Capital and will vest ¼ three months after the date of the grant; ¼ six months after the date of the grant; ¼ nine months after the date of the grant and ¼ twelve months after the date of the grant. The remaining options will vest 1/3 immediately as of the date of grant; 1/3 six months after the date of the grant; and 1/3 12 months after the date of the grant. This stock option grant is subject to acceptance by the TSX Venture Exchange. About Sierra Madre Sierra Madre Gold and Silver Ltd. (TSXV: SM) (OTCQX: SMDRF) is a precious metals development and exploration company focused on the Guitarra mine in the Temascaltepec mining district, Mexico, and the exploration and development of its Tepic property in Nayarit, Mexico. The Guitarra mine is a permitted underground mine, which includes a 500 t/d processing facility that operated until mid-2018 and restarted commercial production in January 2025. The +2,600 ha Tepic Project hosts low-sulphidation epithermal gold and silver mineralization with an existing historic resource. Sierra Madre's management team has played key roles in managing the exploration and development of silver and gold mineral reserves and mineral resources. Sierra Madre's team of professionals has collectively raised over $1 billion for mining companies. On behalf of the board of directors of Sierra Madre Gold and Silver Ltd., "Alexander Langer"Alexander LangerPresident, Chief Executive Officer and Director778-820-1189 Contact:investor@ Cautionary Note Regarding Forward-Looking Information Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. To view the source version of this press release, please visit
Bloomberg
7 days ago
- Business
- Bloomberg
At The Money: Getting Paid in Company Stock
Browse all episodes At The Money: Getting Paid in Company Stock At The Money Getting Paid in Company Stock Arrow Right 16:05 Equity-based compensation has become an increasingly popular form of compensation in the United States, especially in Tech and high-growth, VC-funded companies. Joey Fishman is a Senior Advisor at Ritholtz Wealth Management (RWM), where he assists clients with managing their stock, options, and equity compensation. He joins Barry Ritholtz to discuss essential information about earning pay in stock. Each week, 'At the Money' discusses an important topic in money management. From portfolio construction to taxes and cutting down on fees, join Barry Ritholtz to learn the best ways to put your money to work.
Associated Press
22-07-2025
- Business
- Associated Press
DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ('DiagnaMed' or the 'Company') is pleased to announce that, in accordance with its equity incentive plan, it has issued a total of 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to directors, officers, and consultants of the Company. The RSUs and options were granted as part of DiagnaMed's ongoing efforts to align the interests of its leadership and key partners with those of shareholders, and to reward contributions to the Company's continued growth and development. The 2,500,000 stock options have an exercise price of $0.05 per share and are exercisable for a period of three (3) years from the date of grant. All RSUs and options are subject to the terms and conditions of the Company's equity incentive plan and applicable regulatory approvals. These grants reflect the Board's confidence in the strategic direction of the Company, particularly as it advances its natural hydrogen projects in Ontario alongside its collaborative partners, INRS and QIMC. This initiative underscores DiagnaMed's commitment to driving innovation and growth in the natural hydrogen sector in Ontario. The Company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities within the expanding natural hydrogen sector. This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario. About DiagnaMed Holdings Corp. DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit For more information, please contact: John Karagiannidis, President and CEO DiagnaMed Holdings Corp. Tel: 514-726-7058 Email: [email protected] Website: Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as 'will', 'may', 'expect', 'could', 'can', 'estimate', 'anticipate', 'intend', 'believe', 'projected', 'aims', and 'continue' or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption 'Risk Factors' in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ('MD&A'), dated May 28, 2025, which is available on the Company's profile at Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the '1933 Act') or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. To view the source version of this press release, please visit
Yahoo
22-07-2025
- Business
- Yahoo
DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is pleased to announce that, in accordance with its equity incentive plan, it has issued a total of 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to directors, officers, and consultants of the Company. The RSUs and options were granted as part of DiagnaMed's ongoing efforts to align the interests of its leadership and key partners with those of shareholders, and to reward contributions to the Company's continued growth and development. The 2,500,000 stock options have an exercise price of $0.05 per share and are exercisable for a period of three (3) years from the date of grant. All RSUs and options are subject to the terms and conditions of the Company's equity incentive plan and applicable regulatory approvals. These grants reflect the Board's confidence in the strategic direction of the Company, particularly as it advances its natural hydrogen projects in Ontario alongside its collaborative partners, INRS and QIMC. This initiative underscores DiagnaMed's commitment to driving innovation and growth in the natural hydrogen sector in Ontario. The Company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities within the expanding natural hydrogen sector. This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario. About DiagnaMed Holdings Corp. DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit For more information, please contact: John Karagiannidis, President and CEO DiagnaMed Holdings Corp. Tel: 514-726-7058 Email: info@ Website: Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as "will", "may", "expect", "could", "can", "estimate", "anticipate", "intend", "believe", "projected", "aims", and "continue" or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ("MD&A"), dated May 28, 2025, which is available on the Company's profile at Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. To view the source version of this press release, please visit
Associated Press
17-07-2025
- Business
- Associated Press
TDG Gold Corp. Grants Stock Options
WHITE ROCK, BC / ACCESS Newswire / July 17, 2025 / TDG Gold Corp. (TSXV:TDG)(OTCQX:TDGGF) (the 'Company' or 'TDG') reports that the board of directors of TDG approved the grant of a total of 8,630,000 incentive stock options of the capital stock of the Company to directors, officers, employees and consultants, exercisable for up to a five-year period at an exercise price of $0.60, to vest as to 25% immediately upon grant and 25% each year thereafter, pursuant to the Company's shareholder approved stock option plan. The grant of 8,630,000 incentive stock options of the capital stock of the Company is in line with the Company's annual issuance under its long term incentive plan. ON BEHALF OF THE BOARD Fletcher Morgan Chief Executive Officer For further information contact: TDG Gold Corp. Telephone: +1.604.536.2711 Email: [email protected] Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE: TDG Gold Corp. press release
